Skip to main content
PLOS One logoLink to PLOS One
. 2025 Apr 10;20(4):e0320838. doi: 10.1371/journal.pone.0320838

Overall success rate of permanent teeth pulpotomy using ProRoot MTA: A systematic review and meta-analysis of randomized clinical trials

Emmanuel J N L Silva 1,2,3,*, Karem P Pinto 2, Mahmoud Torabinejad 4, Estefano B Sarmento 2, Jorge N R Martins 5,6,7, Marco A Versiani 1,8, Gustavo De-Deus 1
Editor: Mohmed Isaqali Karobari9
PMCID: PMC11984715  PMID: 40208856

Abstract

Introduction

This systematic review and meta-analysis aimed to evaluate the success rate of pulpotomy in permanent teeth using ProRoot MTA.

Methods

An unrestricted search was carried out in 6 electronic databases, until August 2024. The selection of studies adhered to the PIOS criteria, encompassing only randomized clinical trials that assessed the success rate of pulpotomy in permanent teeth using ProRoot MTA through clinical and radiographic evaluations. Risk of bias was assessed using the RoB-2 tool, and meta-analyses were conducted through RevMan 5.3 and R software. To determine the quality of evidence, the GRADE tool was employed.

Results

The initial search yielded 971 studies. After removing duplicates, 468 studies underwent initial screening, and 32 studies were considered for eligibility. In the final selection, 26 studies were included, and among these, 14 were categorized as having high risk of bias. The analysis of pulpotomy in permanent teeth using ProRoot MTA revealed an overall success rate of 96%, 90%, and 96% at 6-, 12-, and 24-month follow-up periods, respectively, and an annual failure rate of 8%. Meta-analyses indicated a significantly higher success rate for pulpotomies in teeth with open apex. Upon applying the GRADE assessment, an overall moderate level of evidence was observed.

Conclusion

Pulpotomy in permanent teeth using ProRoot MTA yields a success rate exceeding 90%, even up to a 24-month follow-up period. Nonetheless, the certainty of evidence supporting these outcomes is moderate, highlighting the requirement for well-designed randomized clinical trials with extended follow-up durations.

Registration This systematic review was registered in the PROSPERO database (registration number CRD42023451466).

Introduction

Minimally invasive dentistry is founded on the principle of preventing or arresting the disease process in its earliest stages while preserving as much healthy tissue as feasible. In Endodontics, there has been an ongoing search of conservative treatments in permanent teeth affected by deep caries, extensive restorative procedures, or trauma, situations that would otherwise necessitate conventional root canal treatment [1,2]. The expanding range of biocompatible materials developed over the years has highlighted pulpotomy as a compelling alternative for addressing these clinical conditions. This procedure involves the partial or complete removal of inflamed coronal pulp tissue while preserving the remaining healthy pulp, covered by a biomaterial that not only supports tissue repair but also sustains pulp vitality [3,4].

Several randomized clinical trials have demonstrated that pulpotomy results in favorable success rates when addressing exposed pulps in permanent teeth [58]. Previous systematic reviews have also consistently reported an average success rate exceeding 90% for pulpotomy in permanent teeth, even in cases involving teeth with closed apices or irreversible pulpitis [9,10]. Thus, given that a recent systematic review and meta-analysis revealed that the success rate of primary root canal therapy ranged from 82% to 92.6% [11], it can be reasonably inferred that, when appropriately indicated, pulpotomy in permanent teeth may be equally effective when compared to pulpectomy followed by root canal therapy.

The success rate of pulpotomy is directly affected by the choice of biomaterial used on the exposed pulp, which should exhibit biocompatibility, possess anti-inflammatory properties, and support tissue formation [1,12]. Hence, calcium hydroxide and mineral trioxide aggregate (MTA) have traditionally served as primary pulp-capping agents in vital pulp therapy procedures. While calcium hydroxide demonstrates antimicrobial activity and the potential to induce hard tissue barrier formation [13], its use is constrained by factors including high solubility, low mechanical resistance [14], lack of adhesion, and inadequate sealing ability [15] due to tunnel defects formed in the mineralized barrier [16]. These limitations have been recognized as the primary factors accounting for the reduced success rates observed in pulpotomies performed with calcium hydroxide compared to MTA [1,10,14]. As a result, MTA has been established as the primary pulp-capping agent for pulpotomy in young permanent teeth [12] due to its multiple advantages, including biocompatibility, reduced microleakage, capacity to stimulate a thicker dentinal bridge with fewer defects, and the ability to release growth factors from dentine [9,14,17,18]. Amongst the various brands of MTA available in the market, ProRoot MTA (Dentsply Tulsa Dental, Rolling Hills Drive Johnson City, TN, USA) stands out as the most extensively researched and studied [19], largely owing to its status as one of the pioneering calcium-silicate-based cements to be introduced to the market. ProRoot MTA is an inorganic bioactive compound composed of dicalcium and tricalcium silicate as well as tricalcium aluminate. This material has not only demonstrated promising physical properties in laboratory studies [20,21] but has also demonstrated high success rates in pulpotomy procedures conducted on permanent teeth, as evidenced by findings from previous randomized clinical trials [5,2227].

Notwithstanding previous systematic reviews have consistently revealed a high success rate in permanent teeth pulpotomy when employing MTA [1,3,9,10,12], it is noteworthy that these reviews selectively incorporated studies evaluating permanent teeth with distinct characteristics [1,3,9,12] or those that made comparisons between MTA and specific materials [10], thus not encompassing all the studies examining the success of permanent teeth pulpotomy with MTA. Thus, the purpose of this study was to conduct a systematic review and meta-analysis to assess the overall success rate of pulpotomy in permanent teeth when employing ProRoot MTA.

Materials and methods

Review protocol and registration

The systematic review protocol was registered in the PROSPERO database (registration number CRD42023451466) and complies with the Preferred Reporting Items for Systematic Reviews (PRISMA) guidelines [28].

Focused question

This systematic review centered around the following research question: what is the overall rate of success for pulpotomies performed on permanent teeth with ProRoot MTA?

Search strategy

A comprehensive search was conducted independently by two reviewers (K.P.P and E.J.N.L.S.) across multiple electronic databases, including PubMed, Cochrane Library, Scopus, Web of Science, Embase, and Science Direct. The search was performed without any filters, language restrictions, until August 2024. The search strategy was formulated by combining Medical Subject Heading (MeSH) terms and relevant text words associated with the research focus including ProRoot MTA (MeSH Term), ProRoot MTA, Pro Root MTA, pro-root MTA, Proroot MTA, proroot MTA, mineral trioxide aggregate (MeSH Term), pulpotomy (MeSH Term), vital pulp therapy, permanent teeth, mature teeth, dentition permanent (MeSH Term), permanent dentition, and secondary dentition. The search terms were merged using the Boolean operators ‘AND’ and ‘OR’ to construct the search strategies, which are comprehensively outlined in S1 Table. Subsequently, the screening process encompassed a thorough manual review of the references in the chosen studies, and an additional complementary search was performed on OpenGrey literature database.

The articles initially obtained from the search were imported into Endnote X9 Software (Thomson Reuters, New York, NY, USA) to eliminate duplicates. Two authors (K.P.P and E.J.N.L.S.) independently assessed the titles and abstracts, and relevant studies were examined in full to determine eligibility. If there was any disagreement, a third author (G.D.) made the final decision. In cases where the MTA brand was not specified in the study methodology, the authors were contacted via email to certify that it was ProRoot MTA.

Inclusion criteria

The inclusion criteria for this systematic review were established following the PIOS framework, which is detailed below, as the Comparison (C) element in PICOS did not apply to this particular review [29, 30]:

  • P (Population): mature or immature permanent teeth submitted to pulpotomy due to caries or trauma.

  • I (Intervention): partial or full pulpotomy using ProRoot MTA.

  • O (Outcome): success rate based on clinical and radiographic evaluations.

  • S (Study design): randomized clinical trials.

The inclusion criteria for this systematic review encompassed randomized clinical trials specifically assessing the success rate of pulpotomy on permanent teeth with ProRoot MTA. These trials needed to include both clinical and radiographic assessments, with a minimum follow-up period of 6 months. In the clinical evaluation, a minimum of two of the following symptoms should have been assessed: pain, tenderness to percussion, oedema, swelling, or tooth mobility. In terms of radiographic evaluation, at least two of the following signs should have been considered: widening of the periodontal ligament, presence of a periapical lesion, continuity of root formation, or signs of root resorption.

Exclusion criteria

Randomized clinical trials with follow-up periods of less than 6 months, non-randomized clinical trials, and articles that deviated from the study’s focus, such as ex vivo investigations, in vitro experiments, observational studies, animal studies, case reports, serial cases, letters to the editor, opinions, and review articles, were excluded.

Screening protocol

The protocol for selecting and screening scientific papers adhered to a “three-stage assessment” process. In the first stage, the titles and abstracts of the studies were reviewed and categorized as either ‘irrelevant’ or ‘relevant,’ based on predefined inclusion and exclusion criteria. In the second stage, the studies initially identified as relevant underwent a thorough examination of their full text and were once again categorized using the same predefined criteria. Finally, in the third stage, all the chosen papers underwent data extraction, quality assessment, and evaluation of the level of evidence.

Data extraction

The data extraction process was carried out independently by two authors (K.P.P and E.J.N.L.S.) and included the following information: author and publication year, tooth type, sample size for MTA, the status of the roots (mature or immature), reason for pulp exposure, patient age range, pulpal diagnosis, the type of pulpotomy (partial or full), duration of follow-up, success rate, and the annual failure rate (AFR). Any discrepancies were resolved by a third author (G.D.).

Quality assessment

Two authors (K.P.P and E.J.N.L.S.) independently evaluated the quality of the included studies using the RoB-2 tool developed by the Cochrane Collaboration [31]. This tool is specifically designed for assessing the risk of bias in randomized clinical trials and encompasses evaluation in 5 key domains: the randomization process, adherence to intended interventions, handling of missing outcome data, measurement of outcomes, and selection of reported results. Each domain was classified as having ‘low risk’, ‘some concerns’ or ‘high risk’. The overall risk of bias of a study was considered ‘low risk’ if all domains were evaluated as ‘low risk’, ‘some concerns’ if one or more domains were evaluated as ‘some concern’ risk, or ‘high risk’ if any domain was classified as ‘high risk’. In case of discrepancies, a third author (G.D.) was consulted.

Meta-analysis

Meta-analyses of proportions were conducted using R software (Version 3.6.3, R Foundation for Statistical Computing, Vienna, Austria) in conjunction with the packages meta, metafor, and weightr. Forest plots were created to assess the overall success rate of pulpotomies in permanent teeth using ProRoot MTA at 6, 12, and 24 months of follow-up, as well as the AFR. The success rate was determined by taking into account the number of successful cases relative to the total cases, and the AFR was computed by considering the cases of failure in relation to the total cases and the duration of follow-up. The estimate of intervention’s effect was expressed with 95% confidence intervals (CIs). Chi-square test was used to detect statistical heterogeneity with p value set at < 0.1. The I2 statistic was employed to evaluate the degree of heterogeneity, with values greater than 25%, 50%, and 75% signifying low, moderate, or high levels of heterogeneity, respectively. Fixed-effect models were applied in case of low level of heterogeneity, whereas random-effect models were employed in cases of moderate or high heterogeneity. Publication bias were assessed through both visual means, which involved creating funnel plots, and quantitative analysis, using Egger’s regression test with a significance threshold set at p ≤ 0.05. Furthermore, statistical analyses were conducted using RevMan software (Version 5.3, The Cochrane Collaboration) to compare the success rate across various categories, including the status of the root, patient age, pulpal diagnosis, and the type of pulpotomy, and generated corresponding forest plots.

Grading of evidence

The level of evidence was evaluated using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology, with the assistance of the GRADEpro Guideline Development Tool (McMaster University, Hamilton, ON, Canada) [32]. The evaluations were conducted separately by two authors (K.P.P and E.J.N.L.S.) and a third author (G.D.) was consulted in case of discrepancy, considering the following domains: risk of bias, inconsistency, indirectness, imprecision, and publication bias. Each domain was classified as ‘not serious’, ‘serious’ or ‘very serious’ and the overall certainty of evidence was graded into one of four levels: very low, low, moderate or high.

In evaluating the ‘risk of bias’ domain, it was considered the eligibility criteria for patient selection, the inclusion of a control group, the measurement of the intervention and outcomes, the control of confounding factors in the study design or statistical analysis, and the adequacy of follow-up [33]. Ratings were categorized as ‘not serious’ if all the included studies scored more than 3 ‘no’ responses for these parameters, ‘serious’ if there were 2–3 ‘no’ responses, and ‘very serious’ if 1–2 ‘no’ responses were present. In the ‘inconsistency’ domain, it was evaluated whether the studies exhibited consistent effects by taking into account point estimates, their associated confidence intervals, and the criteria for assessing heterogeneity [34]. A rating of ‘not serious’ was assigned when all the included studies displayed consistent results, ‘serious’ when some studies presented inconsistent results, and ‘very serious’ when the majority of the studies exhibited inconsistent outcomes. In the ‘indirectness’ domain, it was examined differences in the population of interest, the nature of the intervention, and the reported outcome. This assessment aimed to ensure the relevance of the study’s patient population to those for whom the intervention is intended and whether the studied outcome holds significant importance for patients [35]. A rating of ‘not serious’ was applied when all the included studies had more than 3 ‘no’ responses for these parameters, ‘serious’ when there were 2–3 ‘no’ responses, and ‘very serious’ when 1–2 ‘no’ responses were noted.

In the ‘imprecision’ domain, the sample size of the included randomized clinical trials and the 95 CI confidence interval surrounding the estimated effect were assessed. It was classified as ‘not serious’ when the combined sample size was very large (with an optimal information size of at least 300) and the 95% CI for the effect estimate (OR) did not encompass substantial benefit or harm (OR ranging from 0.75 to 1.25). On the other hand, it was deemed ‘serious’ if the combined sample size was less than 300 or if the 95% CI for the effect estimate (OR) included significant benefit or harm (OR below 0.75 or above 1.25). It was rated as ‘very serious’ when the combined sample size was less than 300 and the 95% CI for the effect estimate (OR) indicated substantial benefit or harm (OR below 0.75 or above 1.25) [36]. ‘Publication bias’ was evaluated by visually inspecting funnel plots and applying the Egger’s regression statistical test to detect any signs of funnel plot asymmetry [37].

Results

Study selection

The initial search yielded 971 studies (S1 Table, Fig 1). No further studies were identified on OpenGrey. Following the removal of duplicates, 468 studies underwent initial screening based on their titles and abstracts. Out of these, 32 studies were considered eligible and underwent a full-text review (S2 Table). After the full-text review, 6 studies were excluded, leaving 26 studies to be included in the current systematic review [5,7,8,2227,3854]. A screening of the references in the selected studies did not reveal any additional studies for inclusion in this systematic review.

Fig 1. Prisma flow diagram.

Fig 1

Data extraction

Table 1 displays the information collected from the 26 studies included into this systematic review. These studies involved both mature and immature permanent molars with reversible or irreversible pulpitis that underwent either partial or full pulpotomy procedures mainly due to extensive caries lesions. In total, these studies collectively assessed 1118 teeth. It is noteworthy that two articles, Kang et al. [26] and Kang et al. [25], refer to the same clinical trial but with differing follow-up durations. The age range of the patients encompassed a span of 6–82 years, and the duration of the follow-up period ranged from 6 to 78 months. The collective outcomes from the studies indicated a success rate that ranged from 80% to 100%, with an AFR varying between 0% and 15%. The only exceptions were the studies conducted by Kumar et al. [42] which considered teeth with periodontal ligament widening as cases of failure, resulting in a lower radiographic success rate, and the study of Sobh & Ahmed [54] which used apple vinegar or EDTA as final irrigant solution. The other studies used only saline [5,7,22,24,2628,3947,51] or sodium hypochlorite [8,23,25,44,48,49,52,53] as irrigant.

Table 1. Data from the included studies.

Author and year Teeth MTA sample size Mature or immature teeth Cause of pulp exposure Age range (mean age) years Pulpal diagnosis Partial or full pulpotomy Follow-up time: success rate Annual failure rate
Abueniel et al. 2020
[28]
Central incisors n=25 Immature Trauma 7.5-9 Reversible pulpits Full 6 months: 100%
12 months: 88%
18 months: 88%
8.69%
Akhil et al. 2024 [51] Mandibular molars n=30 Mature Caries 16-35 (25.03±1.0) Irreversible pulpitis Full 12 months: 88% 12%
Asgary & Eghbal 2013 [5] Molars n=208 Mature Deep caries 9-65
(26±9)
Irreversible pulpitis Full 12 months: 95% 5.02%
Asgary et al. 2022
[22]
Molars n=55 Mature Deep caries 14-60
(30.80 ± 1.23)
Irreversible pulpitis Full 24 months: 100% 0%
Chailertvanitkul et al. 2014 [23] First molars n= 44 Immature Caries 7-10 Reversible pulpits Partial 6 months: 100%
12 and 24 months: 100%
0%
Cho et al. 2024 [52] Premolars and molars n=44 Mature Caries or trauma 11-82 (44.6± 21.2) Reversible pulpits Partial or full 12 months: 93.9% 8.1%
El Meligy & Avery 2006 [24] Incisors, premolars and molars n=15 Immature Trauma or caries 6-12 Full 6 months: 100%
12 months: 100%
0%
Eppa et al. 2018 [39] n=20 Immature Caries 6-14 Full 3, 6, 9, 12 and 24 months: 100% 0%
Galani et al. 2016 [7] First and second molars n=26 Mature Caries 15-36
(20.56 ± 4.38)
Full 18 months: 85% 10%
Kang et al. 2017 [26] Premolars and molars n=33 Mature and immature Trauma or during caries removal 6-68
(29.3 ± 14.8)
Reversible pulpits Partial 12 months: 96% 4%
Kang et al. 2021 [25] Premolars and molars n=33 Mature and immature Trauma or during caries removal 6-68
(29.3 ± 14.8)
Reversible pulpits Partial 48-78 months: 90% NA*
Keswani et al. 2014 [40] Molars n=26 Immature Caries 6-12
(7.87 ± 2.10)
Full 6, 12 and 24 months: 100% 0%
Koli et al. 2020 [41] Mandibular molars n=30 Mature Caries 18-35
(24.8 ± 5.95)
Irreversible pulpitis with apical periodontitis Full 12 months: 93.3% healed 6.66%
Kumar et al. 2016 [42] Mandibular molars n=19 Mature Caries 14-32
(21.20)
Irreversible pulpitis Full 6 months: 6.7%
12 months: 44.4%
55.55%
Nosrat et al. 2013 [43] First molars n=25 Immature Caries 6-10
(8.28 ± 1.27)
Symptomatic and asymptomatic pulpitis Full 6 months: 66.0% success (complete apical closure); 34.0% healing (progression of apical closure)
12 months: 81.5% success; 18.5% healing
0%
Özgür et al. 2017 [44] Permanent molars n=40 Immature Caries 6-13 Partial 6, 12, 18 and 24 months:
Sodium hypochlorite + ProRoot MTA = 94.4%/
Saline solution + ProRoot MTA = 100%
2%
Qudeimat et al. 2007 [27] First molars n=32 Mature and immature Caries 6.8- 13.3
(10.3 ± 1.8)
Partial 25.4-45.6 months: 93% NA*
Ramani et al. 2021 [45] Mandibular molars n=101 Mature Caries 18-40
(23.32 ± 4.85)
Irreversible pulpitis Partial and full 12 months:
Partial: 80.8%
Full: 89.8%
14.85%
Singh et al. 2023 [53] Molars n=25 Mature Caries 15-45 (29.16 ± 7.63) Reversible pulpits Partial 12 months:
91.3%
8.33%
Sobh & Ahmed 2024 [54] n=40 Mature Caries 18-50 Irreversible pulpitis Full 12 months:
Apple vinager as irrigant solution: 78.6%; EDTA as irrigant solution: 57.1%
17.4%
Taha & Khazali 2017 [8] Molars n=27 Mature Caries 20–52 (30.3 ± 9.6) Irreversible pulpitis Partial 6 months: 84%
12 months: 83%
24 months: 85%
4.16%
Taha et al. 2022 [46] Molars n=50 Mature Caries 10-70 Reversible or irreversible pulpitis Full 6 months: 92.7%
12 months: 91.8%
8.16%
Tozar & Almaz 2020 [47] Mandibular molars n=90 Immature Caries 6-15
(8.6 ± 2.2)
Partial 12 months:
MTA: 88.8%
MTA + laser: 95.5%
Overall: 92.2%
7.78%
Uesrichai et al. 2019 [48] First molars n=37 Mature and Immature Caries 6-18
(10 ±2.1)
Irreversible pulpitis Partial 7-69 months: 92% NA*
Uyar & Alacam 2021 [49] Molars n=18 Immature Caries 6-13
(8.0 ±1.4)
Assymptomatic teeth with vital pulps Partial 12 months: 94.4% 5.55%
Vu et al. 2020 [50] n=25 Immature Caries or trauma 7–13 (9.2 ± 1.5) Reversible pulpitis Partial 6 months: 95.8%
12 months: 95%
4.34%

NA

*: Not available because it was impossible to extract the failures during a specific follow-up time.

Quality assessment

Fig 2 illustrates the assessment of the risk of bias for the 26 studies included in the analysis. Among these, 14 studies were rated as having a high risk of bias due to deviations from the intended interventions [8,2327,39,40,44,46,47,49,50,52]. In this domain, factors such as patient adherence to the intervention, participant recalls, and dropout analysis were taken into consideration. The studies with a high risk of bias did not adequately account for potential dropouts in their sample size calculations or failed to assess how dropouts might influence the trial results. On the other hand, the remaining twelve studies were categorized as having a low risk of bias, as no significant biases were detected during their assessment [5,7,22,38,4143,45,48,51,53,54].

Fig 2. Risk of bias assessment.

Fig 2

Meta-analysis

Meta-analyses using fixed-effect models were conducted to assess the overall success rate of pulpotomies in permanent teeth using ProRoot MTA, considering 6-, 12-, and 24-month follow-up periods, as well as the AFR. Fixed-effect models were employed since there was no substantial heterogeneity observed in these meta-analyses, indicated by Chi-squared values ranging from 1.02 to 3.42 and I² values between 0 and 20%. The success rates for pulpotomy in permanent teeth, assessed at 6-months (11 studies), 12-months (20 studies), and 24-months (6 studies) follow-up periods, were 96% (95% CI: 66–100%; Fig 3A), 90% (95% CI: 72–100%; Fig 3B), and 96% (95% CI: 72–100%; Fig 3C), respectively. The assessment of 23 studies revealed an 8% AFR for pulpotomy in permanent teeth (95% CI: 4–12%; Fig 4), while the funnel plots for all analyses exhibited no substantial asymmetry (S1 Fig). These analyses are corroborated by the results of the Egger’s tests, which consistently yielded non-significant p-values (p = 0.3864 for 6-month, p = 0.3124 for 12-month, p = 0.7861 for 24-month, and p = 0.2672 for AFR). These findings provide support for the absence of significant publication bias within the included studies.

Fig 3. (A) Forest plot of success cases of pulpotomy using ProRoot MTA at the 6-month follow-up showing a 96% of success rate; (B) forest plot of success cases of pulpotomy using ProRoot MTA at the 12-month follow-up indicating a 90% of success rate; (C) forest plot of success cases of pulpotomy using ProRoot MTA at the 24-month follow-up showcasing a 96% success rate.

Fig 3

Fig 4. Forest plot showing an annual failure rate of 8% for pulpotomies using ProRoot MTA.

Fig 4

Meta-analyses using random-effect models were performed to compare the success rates between pulpotomies based on root status, pulpal diagnosis, and the type of pulpotomy. Random-effect models were employed as heterogeneity could not be confirmed. The analysis revealed a higher success rate for pulpotomy in immature teeth when compared to mature teeth (Odds Ratio: 0.70 [CI: 0.49, 1.00, p = 0.05]; S2a Fig). No significant difference in the success rate was noted between partial and full pulpotomy (Odds Ratio: 1.15 [CI: 0.80, 1.66, p = 0.44]; S2b Fig), or between cases of reversible and irreversible pulpitis (Odds Ratio: 1.68 [CI: 0.97, 2.90, p = 0.06]; S2c Fig). The impact of the underlying cause for pulp exposure on the success rate of pulpotomies could not be statistically assessed due to the limited data available. Only one of the included studies specifically investigated teeth that underwent pulpotomy as a result of trauma [38].

Grading of evidence

The evaluation of the evidence quality for the included studies was conducted using the GRADE tool and resulted in an overall moderate quality assessment (Table 2). These studies were labelled as having a ‘serious’ risk of bias because a majority of them failed to adequately address confounding factors, both in their study design and statistical analysis [33]. However, the studies received a ‘not serious’ rating in terms of ‘inconsistency’ because all of them exhibited consistent results, and unexplained heterogeneity was not observed [34]. The domain ‘indirectness’ was also classified as ‘not serious’ since the included studies did not involve indirect comparisons or present indirect results [35]. The populations under study were representative of the patients for whom the interventions are typically recommended, and the assessment of outcomes that matter to patients was ensured.[35] The domain of ‘imprecision’ was rated as ‘serious’ because the required optimal information size was not achieved in the 6-month and 24-month meta-analyses, despite the 95% CI for the effect estimate encompassing noticeable benefits or harms [36]. Furthermore, both funnel plots and Egger’s test provided evidence of the absence of significant publication bias within the included studies [37].

Table 2. Assessment of certainty of evidence.

Certainty assessment
Participants
(studies)
Risk of bias Inconsistency Indirectness Imprecision Publication bias Overall certainty of evidence
1118
(26 randomized clinical trials)
Seriousa Not seriousb Not seriousc Seriousd Nonee ⨁⨁⨁○
MODERATE

a.Most studies showed absence of confounding factors control in the design or statistical analysis.

b.All studies showed consistent results and was not observed unexplained heterogeneity.

c.Populations were representative of the patients for whom the interventions are recommended and patient-important outcomes were assessed.

d.In the meta-analyses of 6-months and 24-months success rate, the pooled sample size was lower than optimal information size, although the 95% CI of the estimative of effect included appreciable benefit or harm.

e.No publication bias was detected in funnel plots and Egger’s tests.

Discussion

Vital pulp therapy is a conservative strategy in the field of Endodontics directed at maintaining the well-being and functionality of the dental pulp. This approach encompasses various procedures, including direct pulp capping, partial pulpotomy, and complete pulpotomy, all designed to safeguard the vitality and normal functions of dental pulps that may be exposed due to factors like caries, trauma, or restorative interventions [55]. The aim of this systematic review and meta-analysis of randomized clinical trials was to assess the overall success rate of pulpotomy in permanent teeth when ProRoot MTA was used as the pulp-capping agent. Our results revealed a success rate exceeding 90%, with a notable 96% success rate at the 24-month follow-up period, accompanied by an AFR of 7%. According to several authors, one significant factor contributing to the failure of vital pulp therapy is the potential for bacterial leakage toward the remaining vital pulp in the root canals, often occurring through a defective restoration, thereby compromising the integrity of the pulp complex sealing [9,5255]. Consequently, it is worth emphasizing that the efficacy of pulpotomy relies heavily on achieving an effective sealing through the use of suitable capping materials and ensuring a proper final restoration. As reported by Alqaderi et al. [9], the success rate of vital pulp therapy may decline over time, underscoring the importance of regular follow-up visits. These visits are essential for the evaluation and potential repair of any flawed restorations, thereby safeguarding the integrity of the dental pulp and enhancing the long-term success of the therapy.

In this review, it was observed that permanent teeth of younger patients with an open apex displayed notably higher success rates in comparison to mature teeth. This outcome aligns with expectations, as the preserved pulp tissue, especially in young and immature teeth, exhibits a high cell count and enhanced vascularity which heightened its resistance against infection and contamination [12]. Furthermore, the presence of a larger population of active dental stem cells within the pulp of immature teeth highlights its significant potential for regenerative treatments, as these specialized cells possess the remarkable capacity to transform into diverse cell types, thereby contributing to a favorable outcome in pulpotomy [57, 58]. Nonetheless, despite the well-established understanding of the age-related decline in dental stem cell regenerative potential [59], it has also been noted that age itself might not serve as a significant risk factor for the success of pulpotomy in mature teeth [9]. Kunert et al. [53] conducted a long-term retrospective study (1–29 years), assessing patients aged 8–79 who had undergone pulpotomy procedures, and their findings led to the conclusion that the patient’s age at the time of pulpotomy did not have a significant impact on the success rates. Moreover, other studies that included patients up to 50 years old have also reported consistently high success rates, [56,6062] suggesting that vital pulp therapy can be equally effective in elderly patients as it is in younger individuals.

The objective of partial pulpotomy is to eliminate the coronally inflamed pulp while retaining the unaffected deeper pulp, and its advantages compared to full pulpotomy encompass preserving cell-rich coronal pulp tissue for enhanced healing potential, as well as facilitating the ongoing deposition of dentine in the cervical region to keep the structural integrity of the tooth [63]. Therefore, the choice between a partial or full pulpotomy is challenging as it hinges on the accurate clinical identification of non-inflamed pulp tissue [1]. The current analyses, in agreement with previous studies [3,45,64], revealed that, despite inconsistencies in the pretreatment diagnostic criteria among selected studies, there were no statistically significant variations in treatment outcomes when comparing different types of pulpotomy (partial and full) or pulpotomy in teeth with reversible or irreversible pulpitis. These findings carry significance as diagnosing pulp vitality in cases of reversible or irreversible pulpitis remains a clinical challenge, primarily due to the lack of precise diagnostic tools and definitive literature-based criteria to distinguish between these conditions [9,13]. The consistent success rates of pulpotomies in teeth with both reversible and irreversible pulpitis may be attributed to the fact that damage and inflammation in these cases are frequently confined to a portion of the coronal pulp [65]. Furthermore, the anti-inflammatory characteristics of tricalcium silicate materials can facilitate the resolution of remaining inflammation and support the preservation of a healthy pulp tissue [17]. Taken together, these observations suggest that removing the coronally inflamed pulp might be adequate to preserve the vitality and health of the non-affected radicular pulp, making pulpotomy an effective procedure for both emergency and definitive treatment in specific patient populations.

In the current review, the quality of evidence in the included studies was generally moderate. Consequently, while the evidence is trustworthy, future research could potentially exert a substantial influence on the estimate of effect [66]. The majority of the studies included in this review were categorized as high risk in terms of bias, primarily because they did not adequately address patient dropout rates during the follow-up period [8,2327,39,40,44,46,47,49,50,52]. It was also noted that substantial differences existed in their methodological approaches, pointing to a lack of consistency in the criteria applied for clinical and radiographic analyses, as well as variations in follow-up periods. Additionally, the optimal information size required was not met in the 6-month and 24-month meta-analyses. It is noteworthy to highlight that, in the present study, while the 12-month follow-up demonstrated a 90% success rate, the 24-month follow-up revealed an even higher success rate of 96%. This apparent improvement in success over time could be attributed to the limited number of studies included in the 24-month analysis. On the other hand, this systematic review and meta-analysis, classified as Level 1a (Systematic review of Randomized Controlled Trials) [67], exhibits several strengths, including: (i) a comprehensive literature search across six major databases, reference lists, and grey literature, without any restrictions, encompassing a meticulous assessment of risk of bias and quality of evidence, carried out by two independent authors, (ii) a detailed meta-analyses to evaluate the overall success rate at three distinct follow-up intervals and to assess the AFR, (iii) a multiple subgroup meta-analyses to evaluate the impact of root status, patient age, pulpotomy type, and pulpal status on the overall success rate of pulpotomy, and (iv) a robust inclusion and exclusion criteria that were used to maintain focus within the review and minimize potential bias arising from study selection.

As observed in this review and consistently emphasized by multiple authors [13,14,68], the current available evidence is inadequate for making definitive conclusions concerning the impact of various factors on pulpotomy outcomes, underscoring the necessity for further high-quality observational studies. A limitation of this review is its potential overlap with previous systematic reviews [10,69] addressing specific aspects of pulpotomy; however, our study uniquely consolidates randomized clinical trial data focusing exclusively on ProRoot MTA’s overall success rate in permanent teeth. These future studies should encompass extended follow-up periods, preferably with a minimum of 2 years [70]. They should also implement a more comprehensive methodology, encompassing robust randomization and blinding techniques [12], while striving for uniformity in the criteria used to assess clinical and radiographic outcomes [13], Furthermore, further research should consistently document patient and tooth-specific variables like age, gender, and tooth type, as well as operator-related factors such as the specialty and experience of the investigator, and technical details concerning the type of pulpotomy, hemostatic agents, biomaterial selection, and permanent restorations [14]. To enhance the applicability and generalizability of results, data from recall appointments should also be included [14]. Additionally, it is imperative to broaden the focus beyond clinical effectiveness and incorporate assessments of cost-effectiveness and quality of life in these future investigations [3]. By addressing these aspects, future studies in the field of pulpotomy can contribute to a more comprehensive understanding and ultimately lead to improved outcomes for patients.

Conclusions

This systematic review and meta-analysis revealed a success rate exceeding 90% for pulpotomy in permanent teeth when employing ProRoot MTA, even after a 24-month follow-up period. While this high success rate offers promise for clinical application, it is noteworthy that the certainty of evidence supporting these results is moderate. Therefore, there is a demand for more extensive, well-designed randomized clinical trials with extended follow-up durations to provide a more comprehensive evaluation of pulpotomy outcomes.

Supporting information

S1 Table. Search terms.

(DOCX)

pone.0320838.s001.docx (14.9KB, docx)
S2 Table. Description of the excluded records and reasons.

(XLS)

pone.0320838.s002.xls (162KB, xls)
S1 Fig

Funnel plots for the meta-analyses: (a) success rate at 6-month follow-up; (b) Success rate at 12-month follow-up; (c) success rate at 24-month follow-up; (d) Annual Failure Rate.

(PNG)

pone.0320838.s003.png (100.2KB, png)
S2 Fig

The forest plots indicated a statistically significant difference between (a) mature and immature teeth. In contrast, there was no significant difference observed in the comparisons of (b) partial and full pulpotomy and (c) teeth with reversible and irreversible pulpitis.

(PNG)

pone.0320838.s004.png (116.2KB, png)
S1 File. PRISMA checklist.

(DOCX)

pone.0320838.s005.docx (32.6KB, docx)

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Li Y, Sui B, Dahl C, Bergeron B, Shipman P, Niu L, et al. Pulpotomy for carious pulp exposures in permanent teeth: A systematic review and meta-analysis. J Dent. 2019;84:1–8. doi: 10.1016/j.jdent.2019.03.010 [DOI] [PubMed] [Google Scholar]
  • 2.Zafar K, Nazeer MR, Ghafoor R, Khan FR. Success of pulpotomy in mature permanent teeth with irreversible pulpitis: A systematic review. J Conserv Dent. 2020;23(2):121–5. doi: 10.4103/JCD.JCD_179_19 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Cushley S, Duncan HF, Lappin MJ, Tomson PL, Lundy FT, Cooper P, et al. Pulpotomy for mature carious teeth with symptoms of irreversible pulpitis: A systematic review. J Dent. 2019;88:103158. doi: 10.1016/j.jdent.2019.06.005 [DOI] [PubMed] [Google Scholar]
  • 4.Leong DJX, Yap AU. Vital pulp therapy in carious pulp-exposed permanent teeth: an umbrella review. Clin Oral Investig. 2021;25(12):6743–56. doi: 10.1007/s00784-021-03960-2 [DOI] [PubMed] [Google Scholar]
  • 5.Asgary S, Eghbal MJ. Treatment outcomes of pulpotomy in permanent molars with irreversible pulpitis using biomaterials: a multi-center randomized controlled trial. Acta Odontol Scand. 2013;71(1):130–6. doi: 10.3109/00016357.2011.654251 [DOI] [PubMed] [Google Scholar]
  • 6.Awawdeh L, Al-Qudah A, Hamouri H, Chakra RJ. Outcomes of Vital Pulp Therapy Using Mineral Trioxide Aggregate or Biodentine: A Prospective Randomized Clinical Trial. J Endod. 2018;44(11):1603–9. doi: 10.1016/j.joen.2018.08.004 [DOI] [PubMed] [Google Scholar]
  • 7.Galani M, Tewari S, Sangwan P, Mittal S, Kumar V, Duhan J. Comparative evaluation of postoperative pain and success rate after pulpotomy and root canal treatment in cariously exposed mature permanent molars: a randomized controlled trial. J Endod. 2017;43(12):1953–62. doi: 10.1016/j.joen.2017.08.007 [DOI] [PubMed] [Google Scholar]
  • 8.Taha NA, Khazali MA. Partial pulpotomy in mature permanent teeth with clinical signs indicative of irreversible pulpitis: a randomized clinical trial. J Endod. 2017;43(9):1417–21. doi: 10.1016/j.joen.2017.03.033 [DOI] [PubMed] [Google Scholar]
  • 9.Alqaderi H. Coronal pulpotomy for cariously exposed permanent posterior teeth with closed apices: A systematic review and meta-analysis. J Dent. 2016;44:1–7. [DOI] [PubMed] [Google Scholar]
  • 10.Silva EJNL, Pinto KP, Belladonna FG, Ferreira CMA, Versiani MA, De-Deus G. Success rate of permanent teeth pulpotomy using bioactive materials: A systematic review and meta-analysis of randomized clinical trials. Int Endod J. 2023;56(9):1024–41. doi: 10.1111/iej.13939 [DOI] [PubMed] [Google Scholar]
  • 11.Burns LE, Kim J, Wu Y, Alzwaideh R, McGowan R, Sigurdsson A. Outcomes of primary root canal therapy: An updated systematic review of longitudinal clinical studies published between 2003 and 2020. Int Endod J. 2022;55(7):714–31. doi: 10.1111/iej.13736 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Chen Y, Chen X, Zhang Y, Zhou F, Deng J, Zou J, et al. Materials for pulpotomy in immature permanent teeth: a systematic review and meta-analysis. BMC Oral Health. 2019;19(1):227. doi: 10.1186/s12903-019-0917-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Donnelly A, Foschi F, McCabe P, Duncan HF. Pulpotomy for treatment of complicated crown fractures in permanent teeth: A systematic review. Int Endod J. 2022;55(4):290–311. doi: 10.1111/iej.13690 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Ather A, Patel B, Gelfond JAL, Ruparel NB. Outcome of pulpotomy in permanent teeth with irreversible pulpitis: a systematic review and meta-analysis. Sci Rep. 2022;12(1):19664. doi: 10.1038/s41598-022-20918-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Mohammadi Z, Dummer PMH. Properties and applications of calcium hydroxide in endodontics and dental traumatology. Int Endod J. 2011;44(8):697–730. doi: 10.1111/j.1365-2591.2011.01886.x [DOI] [PubMed] [Google Scholar]
  • 16.Goldberg F, Massone EJ, Spielberg C. Evaluation of the dentinal bridge after pulpotomy and calcium hydroxide dressing. J Endod. 1984;10(7):318–20. doi: 10.1016/S0099-2399(84)80186-7 [DOI] [PubMed] [Google Scholar]
  • 17.Meschi N, Patel B, Ruparel NB. Material Pulp Cells and Tissue Interactions. J Endod. 2020;46(9S):S150–60. doi: 10.1016/j.joen.2020.06.031 [DOI] [PubMed] [Google Scholar]
  • 18.Nair PNR, Duncan HF, Pitt Ford TR, Luder HU. Histological, ultrastructural and quantitative investigations on the response of healthy human pulps to experimental capping with mineral trioxide aggregate: a randomized controlled trial. Int Endod J. 2008;41(2):128–50. doi: 10.1111/j.1365-2591.2007.01329.x [DOI] [PubMed] [Google Scholar]
  • 19.Pushpalatha C., et al., Modified mineral trioxide aggregate-a versatile dental material: an insight on applications and newer advancements. Front Bioeng Biotechnol, 2022;10:941826. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Camilleri J. The chemical composition of mineral trioxide aggregate. J Conserv Dent. 2008;11(4):141–3. doi: 10.4103/0972-0707.48834 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Kunert M, Lukomska-Szymanska M. Bio-Inductive Materials in Direct and Indirect Pulp Capping-A Review Article. Materials (Basel). 2020;13(5):1204. doi: 10.3390/ma13051204 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Asgary S, Eghbal MJ, Shahravan A, Saberi E, Baghban AA, Parhizkar A. Outcomes of root canal therapy or full pulpotomy using two endodontic biomaterials in mature permanent teeth: a randomized controlled trial. Clin Oral Investig. 2022;26(3):3287–97. doi: 10.1007/s00784-021-04310-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Chailertvanitkul P. Randomized control trial comparing calcium hydroxide and mineral trioxide aggregate for partial pulpotomies in cariously exposed pulps of permanent molars. Int Endod J. 2014;47(9):835–42. [DOI] [PubMed] [Google Scholar]
  • 24.El-Meligy OAS, Avery DR. Comparison of mineral trioxide aggregate and calcium hydroxide as pulpotomy agents in young permanent teeth (apexogenesis). Pediatr Dent. 2006;28(5):399–404. [PubMed] [Google Scholar]
  • 25.Kang C-M, Seong S, Song JS, Shin Y. The role of hydraulic silicate cements on long-term properties and biocompatibility of partial pulpotomy in permanent teeth. Materials (Basel). 2021;14(2):305. doi: 10.3390/ma14020305 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Kang CM, et al., A randomized controlled trial of various MTA materials for partial pulpotomy in permanent teeth. J Dent. 2017;60:8–13. [DOI] [PubMed] [Google Scholar]
  • 27.Qudeimat MA, Barrieshi-Nusair KM, Owais AI. Calcium hydroxide vs mineral trioxide aggregates for partial pulpotomy of permanent molars with deep caries. Eur Arch Paediatr Dent. 2007;8(2):99–104. [DOI] [PubMed] [Google Scholar]
  • 28.Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Leong DJX, de Souza NN, Sultana R, Yap AU. Outcomes of endodontically treated cracked teeth: a systematic review and meta-analysis. Clin Oral Investig. 2020;24(1):465–73. doi: 10.1007/s00784-019-03139-w [DOI] [PubMed] [Google Scholar]
  • 30.Pérez-González F, Molinero-Mourelle P, Sánchez-Labrador L, Sáez-Alcaide L-M, Limones A, Cortés-Bretón Brinkmann J, et al. Assessment of clinical outcomes and histomorphometric findings in alveolar ridge augmentation procedures with allogeneic bone block grafts: A systematic review and meta-analysis. Med Oral Patol Oral Cir Bucal. 2020;25(2):e291–8. doi: 10.4317/medoral.23353 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Sterne JAC, et al., RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. [DOI] [PubMed] [Google Scholar]
  • 32.Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383–94. doi: 10.1016/j.jclinepi.2010.04.026 [DOI] [PubMed] [Google Scholar]
  • 33.Guyatt GH, Oxman AD, Vist G, Kunz R, Brozek J, Alonso-Coello P, et al. GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias). J Clin Epidemiol. 2011;64(4):407–15. doi: 10.1016/j.jclinepi.2010.07.017 [DOI] [PubMed] [Google Scholar]
  • 34.Guyatt GH. GRADE guidelines: 7. Rating the quality of evidence--inconsistency. J Clin Epidemiol. 2011;64(12):1294–302. [DOI] [PubMed] [Google Scholar]
  • 35.Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines: 8. Rating the quality of evidence--indirectness. J Clin Epidemiol. 2011;64(12):1303–10. doi: 10.1016/j.jclinepi.2011.04.014 [DOI] [PubMed] [Google Scholar]
  • 36.Guyatt GH, Oxman AD, Kunz R, Brozek J, Alonso-Coello P, Rind D, et al. GRADE guidelines 6. Rating the quality of evidence--imprecision. J Clin Epidemiol. 2011;64(12):1283–93. doi: 10.1016/j.jclinepi.2011.01.012 [DOI] [PubMed] [Google Scholar]
  • 37.Guyatt GH, Oxman AD, Sultan S, Glasziou P, Akl EA, Alonso-Coello P, et al. GRADE guidelines: 9. Rating up the quality of evidence. J Clin Epidemiol. 2011;64(12):1311–6. doi: 10.1016/j.jclinepi.2011.06.004 [DOI] [PubMed] [Google Scholar]
  • 38.Abuelniel GM, Duggal MS, Kabel N. A comparison of MTA and Biodentine as medicaments for pulpotomy in traumatized anterior immature permanent teeth: A randomized clinical trial. Dent Traumatol. 2020;36(4):400–10. doi: 10.1111/edt.12553 [DOI] [PubMed] [Google Scholar]
  • 39.Eppa HR, Puppala R, Kethineni B, Banavath S, Kanumuri PK, Kishore GVS. Comparative evaluation of three different materials: mineral trioxide aggregate, triple antibiotic paste, and abscess remedy on apical development of vital young permanent teeth. Contemp Clin Dent. 2018;9(2):158–63. doi: 10.4103/ccd.ccd_587_17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Keswani D, Pandey RK, Ansari A, Gupta S. Comparative evaluation of platelet-rich fibrin and mineral trioxide aggregate as pulpotomy agents in permanent teeth with incomplete root development: a randomized controlled trial. J Endod. 2014;40(5):599–605. doi: 10.1016/j.joen.2014.01.009 [DOI] [PubMed] [Google Scholar]
  • 41.Koli B. Combination of nonsurgical endodontic and vital pulp therapy for management of mature permanent mandibular molar teeth with symptomatic irreversible pulpitis and apical periodontitis. J Endod. 2021;47(3):374–81. doi: insert_doi_here [DOI] [PubMed] [Google Scholar]
  • 42.Kumar V, Juneja R, Duhan J, Sangwan P, Tewari S. Comparative evaluation of platelet-rich fibrin, mineral trioxide aggregate, and calcium hydroxide as pulpotomy agents in permanent molars with irreversible pulpitis: A randomized controlled trial. Contemp Clin Dent. 2016;7(4):512–8. doi: 10.4103/0976-237X.194107 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Nosrat A, Seifi A, Asgary S. Pulpotomy in caries-exposed immature permanent molars using calcium-enriched mixture cement or mineral trioxide aggregate: a randomized clinical trial. Int J Paediatr Dent. 2013;23(1):56–63. doi: 10.1111/j.1365-263X.2012.01224.x [DOI] [PubMed] [Google Scholar]
  • 44.Özgür B, Uysal S, Güngör HC. Partial pulpotomy in immature permanent molars after carious exposures using different hemorrhage control and capping materials. Pediatr Dent. 2017;39(5):364–70. [PubMed] [Google Scholar]
  • 45.Ramani A, et al. Comparative evaluation of complete and partial pulpotomy in mature permanent teeth with symptomatic irreversible pulpitis: A randomized clinical trial. International Endodontic Journal. 2022;55(5):430–40. [DOI] [PubMed] [Google Scholar]
  • 46.Taha NA, Al-Rawash MH, Imran ZA. Outcome of full pulpotomy in mature permanent molars using 3 calcium silicate-based materials: A parallel, double blind, randomized controlled trial. International Endodontic Journal. 2022;55(5):416–29. [DOI] [PubMed] [Google Scholar]
  • 47.Tozar KN, Erkmen Almaz M. Evaluation of the Efficacy of Erbium, Chromium-doped Yttrium, Scandium, Gallium, and Garnet Laser in Partial Pulpotomy in Permanent Immature Molars: A Randomized Controlled Trial. J Endod. 2020;46(5):575–83. doi: 10.1016/j.joen.2020.02.003 [DOI] [PubMed] [Google Scholar]
  • 48.Uesrichai N, Nirunsittirat A, Chuveera P, Srisuwan T, Sastraruji T, Chompu-Inwai P. Partial pulpotomy with two bioactive cements in permanent teeth of 6- to 18-year-old patients with signs and symptoms indicative of irreversible pulpitis: a noninferiority randomized controlled trial. Int Endod J. 2019;52(6):749–59. doi: 10.1111/iej.13071 [DOI] [PubMed] [Google Scholar]
  • 49.Uyar DS, Alacam A. Evaluation of partial pulpotomy treatment in cariously exposed immature permanent molars: Randomized controlled trial. Niger J Clin Pract. 2021;24(10):1511–9. doi: 10.4103/njcp.njcp_686_20 [DOI] [PubMed] [Google Scholar]
  • 50.Vu TT, Nguyen MT, Sangvanich P, Nguyen QN, Thunyakitpisal P. Acemannan Used as an Implantable Biomaterial for Vital Pulp Therapy of Immature Permanent Teeth Induced Continued Root Formation. Pharmaceutics. 2020;12(7):644. doi: 10.3390/pharmaceutics12070644 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Akhil VS, Kumar V, Aravind A, Sharma R, Sharma S, Chawla A, et al. Novel cryotherapy technique for pulpotomy in mature permanent teeth with symptomatic irreversible pulpitis- a randomized controlled trial. Clin Oral Investig. 2024;28(5):275. doi: 10.1007/s00784-024-05661-y [DOI] [PubMed] [Google Scholar]
  • 52.Cho SY, Kim J, Lee H, Park S. Randomized clinical trial of pulpotomy using a premixed injectable calcium silicate cement on mature permanent teeth with reversible pulpitis. Scientific Reports. 2024;14(1):2994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Singh DVV, Taneja S, Fatima S. Comparative evaluation of treatment outcome of partial pulpotomy using different agents in permanent teeth-a randomized controlled trial. Clin Oral Investig. 2023;27(9):5171–80. doi: 10.1007/s00784-023-05136-6 [DOI] [PubMed] [Google Scholar]
  • 54.Sobh YTM, Ahmed MRA. The effect of two different contemporary chelating agents on vital pulp therapy in mature permanent teeth with irreversible pulpitis using bioceramic material: randomized clinical trial. BMC Oral Health. 2024;24(1):918. doi: 10.1186/s12903-024-04627-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Duncan HF. Present status and future directions-Vital pulp treatment and pulp preservation strategies. Int Endod J. 2022;55 Suppl 3(Suppl 3):497–511. doi: 10.1111/iej.13688 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Simon S. Should pulp chamber pulpotomy be seen as a permanent treatment? Some preliminary thoughts. International Endodontic Journal. 2013;46(1):79–87. [DOI] [PubMed] [Google Scholar]
  • 57.Cohenca N, Paranjpe A, Berg J. Vital pulp therapy. Dent Clin North Am. 2013;57(1):59–73. doi: 10.1016/j.cden.2012.09.004 [DOI] [PubMed] [Google Scholar]
  • 58.Mass E, Zilberman U. Long-term radiologic pulp evaluation after partial pulpotomy in young permanent molars. Quintessence Int. 2011;42(7):547–54. [PubMed] [Google Scholar]
  • 59.Maeda H. Aging and Senescence of Dental Pulp and Hard Tissues of the Tooth. Front Cell Dev Biol. 2020;8:605996. doi: 10.3389/fcell.2020.605996 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Asgary S, Eghbal MJ, Ghoddusi J. Two-year results of vital pulp therapy in permanent molars with irreversible pulpitis: an ongoing multicenter randomized clinical trial. Clin Oral Investig. 2014;18(2):635–41. doi: 10.1007/s00784-013-1003-6 [DOI] [PubMed] [Google Scholar]
  • 61.Barngkgei IH, Halboub ES, Alboni RS, Pulpotomy of symptomatic permanent teeth with carious exposure using mineral trioxide aggregate. Iran Endod J. 2013;8(2):65–8. [PMC free article] [PubMed] [Google Scholar]
  • 62.DeRosa TA. A retrospective evaluation of pulpotomy as an alternative to extraction. Gen Dent. 2006;54(1):37–40. [PubMed] [Google Scholar]
  • 63.Cvek M. A clinical report on partial pulpotomy and capping with calcium hydroxide in permanent incisors with complicated crown fracture. J Endod. 1978;4(8):232–7. doi: 10.1016/S0099-2399(78)80153-8 [DOI] [PubMed] [Google Scholar]
  • 64.Jassal A, Nawal RR, Yadav S, Talwar S, Yadav S, Duncan HF. Outcome of partial and full pulpotomy in cariously exposed mature molars with symptoms indicative of irreversible pulpitis: A randomized controlled trial. Int Endod J. 2023;56(3):331–44. doi: 10.1111/iej.13872 [DOI] [PubMed] [Google Scholar]
  • 65.Ricucci D, Loghin S, Siqueira JF Jr. Correlation between clinical and histologic pulp diagnoses. J Endod. 2014;40(12):1932–9. doi: 10.1016/j.joen.2014.08.010 [DOI] [PubMed] [Google Scholar]
  • 66.Atkins D, Eccles M, Flottorp S, Guyatt GH, Henry D, Hill S, et al. Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group. BMC Health Serv Res. 2004;4(1):38. doi: 10.1186/1472-6963-4-38 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.The Joanna Briggs Institute Levels of Evidence and Grades of Recommendation Working Party, JBI Levels of Evidence https://jbi.global/sites/default/files/2019-05/JBI-Levels-of-evidence_2014_0.pdf, 2013: p. [Accessed on 13 September 2023]. [Google Scholar]
  • 68.Duncan HF, El-Karim I, Dummer PMH, Whitworth J, Nagendrababu V. Factors that influence the outcome of pulpotomy in permanent teeth. Int Endod J. 2023;56 Suppl 2:62–81. doi: 10.1111/iej.13866 [DOI] [PubMed] [Google Scholar]
  • 69.Li W, Yang B, Shi J. Efficacy of pulpotomy for permanent teeth with carious pulp exposure: A systematic review and meta-analysis of randomized controlled trials. PLoS One. 2024;19(7):e0305218. doi: 10.1371/journal.pone.0305218 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Ng YL, Mann V, Gulabivala K. Outcome of secondary root canal treatment: a systematic review of the literature. Int Endod J. 2008. 41(12):1026–46. [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Mohmed Isaqali Karobari

3 Jan 2025

PONE-D-24-38286Overall success rate of permanent teeth pulpotomy using ProRoot MTA: a systematic review and meta-analysis of randomized clinical trialsPLOS ONE

Dear Dr. Silva,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

Dear Authors,

Kindly read all the comments given by the reviewers carefully and address them; make the changes in the revised manuscript accordingly.

Best regards and keep well

==============================

Please submit your revised manuscript by Feb 17 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Mohmed Isaqali Karobari, BDS, MScD.Endo, Ph.D. Endo, FDS, FPFA, MFDS

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Peer review at PLOS ONE is not double-blinded (https://journals.plos.org/plosone/s/editorial-and-peer-review-process). For this reason, authors should include in the revised manuscript all the information removed for blind review.

3. As required by our policy on Data Availability, please ensure your manuscript or supplementary information includes the following:

A numbered table of all studies identified in the literature search, including those that were excluded from the analyses. 

For every excluded study, the table should list the reason(s) for exclusion. 

If any of the included studies are unpublished, include a link (URL) to the primary source or detailed information about how the content can be accessed.

A table of all data extracted from the primary research sources for the systematic review and/or meta-analysis. The table must include the following information for each study:

Name of data extractors and date of data extraction

Confirmation that the study was eligible to be included in the review. 

All data extracted from each study for the reported systematic review and/or meta-analysis that would be needed to replicate your analyses.

If data or supporting information were obtained from another source (e.g. correspondence with the author of the original research article), please provide the source of data and dates on which the data/information were obtained by your research group.

If applicable for your analysis, a table showing the completed risk of bias and quality/certainty assessments for each study or outcome.  Please ensure this is provided for each domain or parameter assessed. For example, if you used the Cochrane risk-of-bias tool for randomized trials, provide answers to each of the signalling questions for each study. If you used GRADE to assess certainty of evidence, provide judgements about each of the quality of evidence factor. This should be provided for each outcome. 

An explanation of how missing data were handled.

This information can be included in the main text, supplementary information, or relevant data repository. Please note that providing these underlying data is a requirement for publication in this journal, and if these data are not provided your manuscript might be rejected. 

Additional Editor Comments:

Dear Authors,

Kindly read all the comments given by the reviewers carefully and address them; make the changes in the revised manuscript accordingly.

Best regards and keep well

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: No

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: I thank the Editorial Board of PLoS One for the opportunity to review the manuscript titled "Overall success rate of permanent teeth pulpotomy using ProRoot MTA: a systematic review and meta-analysis of randomized clinical trials." I commend the authors for their efforts on the manuscript so far. However, the article has significant limitations that cannot be addressed through revision, which prevents me from recommending its publication. Despite the efforts to meta-analyze the data, the data handling was not appropriate. First, a fixed-effect analysis assumes that all studies evaluated a common true effect and that the differences among the results are due only to chance or sampling error. However, upon reviewing the included studies, there are potential sources of discrepancies, whether due to diagnostic criteria, sample characteristics, the pulpotomy protocol applied, or even the potential biases identified by the RoB assessment. The subgroup analysis does not align with the stated objective; a meta-regression would be more appropriate. Furthermore, treatment-related protocols were not even considered by the authors, except for the biomaterial used. While I understand this is the primary focus of the study, the pulpotomy technique is far more comprehensive, and its outcome is not solely dependent on the capping biomaterial used. In addition, There is a clear lack of novelty in the review, and the data duplicates findings from other recently published reviews with a more focused research question. Other reviews have investigated the outcomes of pulpotomy in various aspects: partial vs. total, immature vs. mature teeth, irreversible vs. reversible pulpitis, or even according to the etiology of the indication. Moreover, the findings of this review have already been confirmed in the literature, where the success rate of pulpotomy using ProRoot MTA is significantly higher than when using calcium hydroxide. Please refer to (1) Silva EJNL, Pinto KP, Belladonna FG, Ferreira CMA, Versiani MA, De-Deus G. Success rate of permanent teeth pulpotomy using bioactive materials: A systematic review and meta-analysis of randomized clinical trials. Int Endod J. 2023 Sep;56(9):1024-1041. doi: 10.1111/iej.13939. (2) Li W, Yang B, Shi J. Efficacy of pulpotomy for permanent teeth with carious pulp exposure: A systematic review and meta-analysis of randomized controlled trials. PLoS One. 2024 Jul 5;19(7). doi: 10.1371/journal.pone.0305218.

Reviewer #2: The submitted paper, titled "Overall Success Rate of Permanent Teeth Pulpotomy Using ProRoot MTA: A Systematic Review and Meta-Analysis of Randomized Clinical Trials," aimed to evaluate the success rate of pulpotomy in permanent teeth using ProRoot MTA through a systematic review and meta-analysis. This review is highly relevant to the field of Endodontics and adheres to established guidelines.

Overall, the paper is well-written. This reviewer has only minor suggestions to enhance its readability.

Minor comments:

- Page 2. Abstract: Replace "RevMan 5.3 and R software" with "RevMan 5.3 and R softwares."

- Page 5. Line 4: Correct "MTA been established" to "MTA has been established."

- Page 5. Line 8: Include the city, state, and country of Dentsply Tulsa Dental.

- Page 6. Line 4 (Search strategy): The phrase "The search was performed without any filters, language restrictions, or August 2024" is incomplete and requires clarification.

- Page 12. Line 2: Replace "evolved" with "involved."

- Page 12. Line 8: Use the abbreviation AFR (Annual Failure Rate), as it was already defined earlier.

- Page 16: Revise "the remaining nine studies were categorized as having a low risk of bias" to reflect the correct number of studies, which is likely 12.

- Page 16. Line 3 (Meta-analysis): Use the abbreviation AFR instead of the full term Annual Failure Rate.

- Page 17. Line 1: Change "The assessment of 23 studies" to "The assessment of 26 studies," as the correct number is 26.

- Page 17. Line 1: Use AFR for consistency instead of spelling out Annual Failure Rate.

- Page 17. Line 9: The phrase "Random-effect models were employed as heterogeneity could not be established" appears incomplete and needs clarification or additional context.

- Page 19. Line 5: Replace "randomized clinical trials was to assess" with "RCTs was to assess."

- Page 19. Line 7: Use AFR instead of spelling out Annual Failure Rate.

- Page 19. Line 8: Correct the Annual Failure Rate to 8%, as the reported value is incorrect.

- Page 19: Revise "In this review, it was observed that permanent teeth of younger patients with an open apex displayed notably higher success rates in comparison to mature teeth, respectively." The word "respectively" seems misplaced and should be removed or rephrased for clarity.

Reviewer #3: Thank you for the opportunity to review the manuscript titled “Overall success rate of permanent teeth pulpotomy using ProRoot MTA: a systematic review and meta-analysis of randomized clinical trials.”

I am pleased to inform you that I found the manuscript to be exceptionally well-written, with a clear and concise presentation of the research. The authors have done an excellent job in articulating their findings and supporting them with robust evidence.

I have no recommendations for revisions or improvements, as the manuscript meets the high standards expected for publication in PLOS One.

Reviewer #4: The article present relevant information for Endodontic practice and it was well designed. This article will show that MTA is still relevant and that bioceramic cements are not as essential as they are trying to make them out to be.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Reviewer #4: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

PLoS One. 2025 Apr 10;20(4):e0320838. doi: 10.1371/journal.pone.0320838.r003

Author response to Decision Letter 1


23 Jan 2025

Dear Dr. Mohmed Isaqali Karobari

Academic Editor of PLOS ONE

On behalf of co-authors, I am submitting the revised version of the manuscript PONE-D-24-38286 entitled Overall success rate of permanent teeth pulpotomy using ProRoot MTA: a systematic review and meta-analysis of randomized clinical trials to the PLoS One Journal. We would like to express our gratitude to you and the reviewers for their meticulous and insightful review of our work. Considering their valuable suggestions and comments, we have made some revisions to the manuscript. To clearly highlight these changes, we have marked them in blue throughout the document. We appreciate the opportunity to contribute to the PLoS One Journal and look forward to your favorable decision.

Reviewer #1

I thank the Editorial Board of PLoS One for the opportunity to review the manuscript titled "Overall success rate of permanent teeth pulpotomy using ProRoot MTA: a systematic review and meta-analysis of randomized clinical trials." I commend the authors for their efforts on the manuscript so far. However, the article has significant limitations that cannot be addressed through revision, which prevents me from recommending its publication.

Response: We thank Reviewer #1 for their thorough review and constructive comments on our manuscript. Below, we address each concern point by point, providing clarifications and justifications for our methodology and approach.

1. Despite the efforts to meta-analyze the data, the data handling was not appropriate. First, a fixed-effect analysis assumes that all studies evaluated a common true effect and that the differences among the results are due only to chance or sampling error. However, upon reviewing the included studies, there are potential sources of discrepancies, whether due to diagnostic criteria, sample characteristics, the pulpotomy protocol applied, or even the potential biases identified by the RoB assessment.

Response: We thank the reviewer concern. We also acknowledge the reviewer’s observation regarding the fixed-effect model. We chose this model because the statistical heterogeneity observed in our analyses was minimal, with I² values ranging from 0% to 20%. This indicator supports the appropriateness of a fixed-effect model in this context. Moreover, random-effects models were used in subgroup analyses where heterogeneity was higher. Importantly, this approach was conducted following the advice of our Biostatistical Advisor, who recommended using fixed-effect models for overall analyses with low heterogeneity and random-effects models for subgroup analyses to ensure methodological accuracy. Our approach aligns with established meta-analytic practices and ensures that the data handling reflects the characteristics of the included studies.

2. The subgroup analysis does not align with the stated objective; a meta-regression would be more appropriate.

Response: We also thank the reviewer for this concern. Although we understand the reviewer comment, we opted for subgroup analyses rather than meta-regression due to the limited number of included studies and the lack of sufficient covariates to perform a reliable meta-regression. Subgroup analyses allowed us to explore variations in success rates across key factors while maintaining statistical robustness. Conducting meta-regression with sparse data could risk overfitting and lead to unreliable conclusions, which we aimed to avoid. This approach was also recommended by our Biostatistical Advisor, who emphasized that subgroup analyses were the most suitable method given the data characteristics and the study design.

3. Furthermore, treatment-related protocols were not even considered by the authors, except for the biomaterial used. While I understand this is the primary focus of the study, the pulpotomy technique is far more comprehensive, and its outcome is not solely dependent on the capping biomaterial used.

Response: We thank the reviewer for this comment which is interesting indeed. While we agree that pulpotomy outcomes are influenced by multiple factors, our study's primary focus was on evaluating the success rate of ProRoot MTA as a capping material. However, we did consider and discuss other treatment-related factors, such as the type of pulpotomy (partial or full), root maturity, and pulpal diagnosis, in our subgroup analyses. A more comprehensive evaluation of additional treatment protocols (such as hemostatic agents, operator expertise) could be an avenue for future research, as detailed in the end of our discussion section.

4. In addition, there is a clear lack of novelty in the review, and the data duplicates findings from other recently published reviews with a more focused research question. Other reviews have investigated the outcomes of pulpotomy in various aspects: partial vs. total, immature vs. mature teeth, irreversible vs. reversible pulpitis, or even according to the etiology of the indication.

Response: We thank the reviewer for this comment. In our point of view, the present systematic review provides a unique contribution by exclusively focusing on ProRoot MTA, the most extensively studied MTA brand, and consolidating evidence from randomized clinical trials. While other reviews have explored broader or more specific aspects of pulpotomy, none have comprehensively synthesized RCT data on ProRoot MTA’s overall success rate in permanent teeth across various contexts. This focused approach ensures clinically relevant insights for practitioners using this specific biomaterial. Furthermore, we explicitly acknowledge in the Introduction section the existence of prior systematic reviews and discuss their limitations, such as selective inclusion criteria and narrower scopes. Our work builds upon these prior efforts to address these gaps and provide a comprehensive and clinically valuable synthesis of the available evidence. However, in order to avoid disappointing the reviewer, we have added it now to a new limitations sentence in the Discussion.

5. Moreover, the findings of this review have already been confirmed in the literature, where the success rate of pulpotomy using ProRoot MTA is significantly higher than when using calcium hydroxide.

Response: We have appreciated the reviewer concern. In our perspective, while the higher success rate of ProRoot MTA compared to calcium hydroxide is documented, our study extends this knowledge by presenting an updated and rigorous meta-analysis of 26 RCTs. Additionally, we evaluated success rates at multiple follow-up periods (6, 12, and 24 months), assessed the annual failure rate, and conducted subgroup analyses, offering a more granular understanding of ProRoot MTA’s performance in different clinical scenarios.

6. Please refer to (1) Silva EJNL, Pinto KP, Belladonna FG, Ferreira CMA, Versiani MA, De-Deus G. Success rate of permanent teeth pulpotomy using bioactive materials: A systematic review and meta-analysis of randomized clinical trials. Int Endod J. 2023 Sep;56(9):1024-1041. doi: 10.1111/iej.13939. (2) Li W, Yang B, Shi J. Efficacy of pulpotomy for permanent teeth with carious pulp exposure: A systematic review and meta-analysis of randomized controlled trials. PLoS One. 2024 Jul 5;19(7). doi: 10.1371/journal.pone.0305218.

Response: We appreciate this recommendation. The study (1) was already part of the bibliographic reference list, while the study (2) has now been added.

Reviewer #2

The submitted paper, titled "Overall Success Rate of Permanent Teeth Pulpotomy Using ProRoot MTA: A Systematic Review and Meta-Analysis of Randomized Clinical Trials," aimed to evaluate the success rate of pulpotomy in permanent teeth using ProRoot MTA through a systematic review and meta-analysis. This review is highly relevant to the field of Endodontics and adheres to established guidelines.

Overall, the paper is well-written. This reviewer has only minor suggestions to enhance its readability.

Response: We thank Reviewer #2 for their thorough review and constructive comments on our manuscript. All requested changes were performed as suggested by the reviewer.

Minor comments:

- Page 2. Abstract: Replace "RevMan 5.3 and R software" with "RevMan 5.3 and R softwares."

Response: Considering that “software” is an uncountable noun, the plural should be software. Therefore, in this specific point we do not made any modification.

- Page 5. Line 4: Correct "MTA been established" to "MTA has been established."

Response: Thank you! We have changed.

- Page 5. Line 8: Include the city, state, and country of Dentsply Tulsa Dental.

Response: It was added as suggested by the reviewer.

- Page 6. Line 4 (Search strategy): The phrase "The search was performed without any filters, language restrictions, or August 2024" is incomplete and requires clarification.

Response: Thank you! We have changed!

- Page 12. Line 2: Replace "evolved" with "involved."

Response: Thank you! We have changed!

- Page 12. Line 8: Use the abbreviation AFR (Annual Failure Rate), as it was already defined earlier.

Response: Thank you! We have changed!

- Page 16: Revise "the remaining nine studies were categorized as having a low risk of bias" to reflect the correct number of studies, which is likely 12.

Response: Thank you! It was changed.

- Page 16. Line 3 (Meta-analysis): Use the abbreviation AFR instead of the full term Annual Failure Rate.

Response: Thank you! We have changed!

- Page 17. Line 1: Change "The assessment of 23 studies" to "The assessment of 26 studies," as the correct number is 26.

Response: In fact for this specific assessment 23 studies were evaluated. Please check figure 4.

- Page 17. Line 1: Use AFR for consistency instead of spelling out Annual Failure Rate.

Response: Thank you! We have changed!

- Page 17. Line 9: The phrase "Random-effect models were employed as heterogeneity could not be established" appears incomplete and needs clarification or additional context.

Response: Thank you! We have changed!

- Page 19. Line 5: Replace "randomized clinical trials was to assess" with "RCTs was to assess."

Response: Thank you! We have eliminated RCT and used randomized clinical trial in the entire manuscript.

- Page 19. Line 7: Use AFR instead of spelling out Annual Failure Rate.

Response: Thank you! We have changed

- Page 19. Line 8: Correct the Annual Failure Rate to 8%, as the reported value is incorrect.

Response: Thank you! We have changed

- Page 19: Revise "In this review, it was observed that permanent teeth of younger patients with an open apex displayed notably higher success rates in comparison to mature teeth, respectively." The word "respectively" seems misplaced and should be removed or rephrased for clarity.

Response: Thank you! It was removed.

Reviewer #3

Thank you for the opportunity to review the manuscript titled “Overall success rate of permanent teeth pulpotomy using ProRoot MTA: a systematic review and meta-analysis of randomized clinical trials.”

I am pleased to inform you that I found the manuscript to be exceptionally well-written, with a clear and concise presentation of the research. The authors have done an excellent job in articulating their findings and supporting them with robust evidence.

I have no recommendations for revisions or improvements, as the manuscript meets the high standards expected for publication in PLOS One.

Response: We thank Reviewer #3 for their thorough review and constructive comments on our manuscript

Reviewer #4

The article present relevant information for Endodontic practice and it was well designed. This article will show that MTA is still relevant and that bioceramic cements are not as essential as they are trying to make them out to be.

Response: We thank Reviewer #4 for their thorough review and constructive comments on our manuscript

Attachment

Submitted filename: Response to the reviewers.docx

pone.0320838.s007.docx (21.4KB, docx)

Decision Letter 1

Mohmed Isaqali Karobari

26 Feb 2025

Overall success rate of permanent teeth pulpotomy using ProRoot MTA: a systematic review and meta-analysis of randomized clinical trials

PONE-D-24-38286R1

Dear Dr. Silva,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Mohmed Isaqali Karobari, BDS, MScD.Endo, Ph.D. Endo, FDS, FPFA, MFDS

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Dear Authors,

The authors have addressed all the comments and suggestions reviewers gave, and the manuscript has dramatically improved. The manuscript can be accepted for publication in its current form. I would like to congratulate the authors and wish them all the very best in their future endeavours.

Best regards and keep well

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: This reviewer would like to thank the authors for the modifications made. I accept the paper in its current form.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #2: No

**********

Acceptance letter

Mohmed Isaqali Karobari

PONE-D-24-38286R1

PLOS ONE

Dear Dr. Silva,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Prof Dr. Mohmed Isaqali Karobari

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Search terms.

    (DOCX)

    pone.0320838.s001.docx (14.9KB, docx)
    S2 Table. Description of the excluded records and reasons.

    (XLS)

    pone.0320838.s002.xls (162KB, xls)
    S1 Fig

    Funnel plots for the meta-analyses: (a) success rate at 6-month follow-up; (b) Success rate at 12-month follow-up; (c) success rate at 24-month follow-up; (d) Annual Failure Rate.

    (PNG)

    pone.0320838.s003.png (100.2KB, png)
    S2 Fig

    The forest plots indicated a statistically significant difference between (a) mature and immature teeth. In contrast, there was no significant difference observed in the comparisons of (b) partial and full pulpotomy and (c) teeth with reversible and irreversible pulpitis.

    (PNG)

    pone.0320838.s004.png (116.2KB, png)
    S1 File. PRISMA checklist.

    (DOCX)

    pone.0320838.s005.docx (32.6KB, docx)
    Attachment

    Submitted filename: Rebuttal letter.docx

    pone.0320838.s006.docx (13KB, docx)
    Attachment

    Submitted filename: Response to the reviewers.docx

    pone.0320838.s007.docx (21.4KB, docx)

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES